Speaker(s): 

Cosmin Sandulescu, MD, MS - Geisinger - has nothing to disclose.

Moderator(s): 

Jessica Goldhirsh, MD, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the neuropathologic mechanisms underlying tardive dyskinesia.
• Apply current diagnostic criteria to accurately identify and diagnose it.
• Evaluate available and emerging therapeutic strategies for tardive dyskinesia, and recommend evidence-based approaches tailored to individual patient needs.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Margaret Jarvis, MD, Jessica Sevecke-Hanrahan, PhD, Jessie Goldhirsh, MD, Kati Mahlmann, LCSW, Priscilla Riley, LPC, Imad Melhem, MD, and DeAnn Hansum, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None